Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Joanna Szkandera"'
Autor:
Marisa Valentini, Joanna Szkandera, Maria Anna Smolle, Susanne Scheipl, Andreas Leithner, Dimosthenis Andreou
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
IntroductionSince its introduction in November 2022, the artificial intelligence large language model ChatGPT has taken the world by storm. Among other applications it can be used by patients as a source of information on diseases and their treatment
Externí odkaz:
https://doaj.org/article/a7d72467acfd4941802fe054cfdf26f0
Autor:
Hanna Henzinger, Iva Brčić, Jasminka Igrec, Theresa Marie Godschachner, Susanne Scheipl, Joanna Szkandera, Philipp Jurmeister, Bernadette Liegl-Atzwanger
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 10, p 5105 (2024)
Cellular myxoma is a benign soft tissue tumor frequently associated with GNAS mutation that may morphologically resemble low-grade myxofibrosarcoma. This study aimed to identify the undescribed methylation profile of cellular myxoma and compare it to
Externí odkaz:
https://doaj.org/article/c3c3b0746f304b7fb749f3895e3d2cfa
Autor:
Anna Maria Frezza, Hugh Leonard, Ninna Aggerholm-Pedersen, Giuseppe Badalamenti, Paolo Baili, Giacomo G Baldi, Sebastian Bauer, Serena Bazzurri, Irene Benzonelli, Alexia Bertuzzi, Jean-Yves Blay, Giuseppe Bianchi, Simone Bonfarnuzzo, Christophe Bouvier, Kyetil Boye, Javier Martin Broto, Antonella Brunello, Domenico Campanacci, Paolo G Casali, Carlo Cicala, Elisa Crotti, Lorenzo D'Ambrosio, Angelo Paolo Dei Tos, Nils Dieckmann, Armelle Dufresne, Stephanie Elston, Virginia Ferraresi, Stefano Gabellini, Claudia Giani, Vincenzo Giannusa, Melissa Gil Sanjines, Teresa Grassani, Alessandro Gronchi, Paolo Lasalvia, Stefan Lindskog, Nadia Hindi, Matilde Ingrosso, Andrei Ivanescu, Robin Jones, Iwona Lugowska, Julia Ketzer, Anna Mariuk-Jarema, Alessandro Mazzocca, Laura Monteleone, Carlo Morosi, Andrea Napolitano, Francesca Nardozza, Elisabetta Neri, Maria Nilsson, Andri Papakonstantinou, Sandro Pasquali, Marta Sbaraglia, Federico Scolari, Joanna Szkandera, Claudia Valverde, Bruno Vincenzi, Salvatore Vizzaccaro, Federica Zuccheri, Silvia Stacchiotti, Annalisa Trama
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0308387 (2024)
IntroductionEpithelioid hemangioendothelioma (EHE) is an ultra-rare sarcoma, marked by distinctive molecular and pathological features and with a variable clinical behavior. Its natural history is still partially understood, reliable prognostic and p
Externí odkaz:
https://doaj.org/article/437c63f0b21f4d4db2adca8416449656
Autor:
Maya Niethard, Carolin Knebel, Andreas Leithner, Per-Ulf Tunn, Janosch Schoon, Peter Reichardt, Athanasios Pogkas, Joanna Szkandera, Daniel Pink, Dimosthenis Andreou
Publikováno v:
Cancers, Vol 16, Iss 9, p 1633 (2024)
Primary leiomyosarcoma of bone (LMSoB) is extremely rare, comprising only p = 0.0015). Axial tumor localization was associated with worse event-free survival (EFS) probability (p < 0.001) and OS (p = 0.0082). A high proportion of our patients develop
Externí odkaz:
https://doaj.org/article/85dfb09fb45046efabdf12a911ab215e
Autor:
Maria Anna Smolle, Wolfgang Helmberg, Eva Maria Matzhold, Dominik Andreas Barth, Nazanin Sareban, Joanna Szkandera, Bernadette Liegl‐Atzwanger, Andreas Leithner, Martin Pichler
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1237-1246 (2023)
Abstract Background Perioperatively administered (leukocyte reduced) allogeneic red blood cell transfusions (lrRBCTs) may lead to transfusion‐related immunomodulation and reduced overall survival (OS) in cancer patients. Herein, the effect of lrRBC
Externí odkaz:
https://doaj.org/article/c77ed348a92049c6b254dbce1ebdf3e4
Autor:
Christina Karner, Ines Anders, Djenana Vejzovic, Joanna Szkandera, Susanne Scheipl, Alexander J. A. Deutsch, Larissa Weiss, Klemens Vierlinger, Dagmar Kolb, Stefan Kühberger, Ellen Heitzer, Hansjörg Habisch, Fangrong Zhang, Tobias Madl, Birgit Reininger-Gutmann, Bernadette Liegl-Atzwanger, Beate Rinner
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-19 (2023)
Abstract Background Clear cell sarcomas (CCSs) are translocated aggressive malignancies, most commonly affecting young adults with a high incidence of metastases and a poor prognosis. Research into the disease is more feasible when adequate models ar
Externí odkaz:
https://doaj.org/article/fae2cfc0f5e64159baebde84535c5f30
Autor:
Dominik A. Barth, Stefanie Stanzer, Jasmin Spiegelberg, Thomas Bauernhofer, Gudrun Absenger, Florian Posch, Rainer Lipp, Michael Halm, Joanna Szkandera, Marija Balic, Armin Gerger, Maria A. Smolle, Georg C. Hutterer, Christiane Klec, Philipp J. Jost, Julia Kargl, Martin Stradner, Martin Pichler
Publikováno v:
Cancer Medicine, Vol 11, Iss 16, Pp 3074-3083 (2022)
Abstract Background The presence of autoantibodies in the serum of cancer patients has been associated with immune‐checkpoint inhibitor (ICI) therapy response and immune‐related adverse events (irAEs). A prospective evaluation of different autoan
Externí odkaz:
https://doaj.org/article/8914eb1a50484886b516dc8999f59708
Autor:
Markus G. Seidel, Karl Kashofer, Tina Moser, Andrea Thueringer, Bernadette Liegl-Atzwanger, Andreas Leithner, Joanna Szkandera, Martin Benesch, Amin El-Heliebi, Ellen Heitzer
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
BackgroundTreatment stratification and response assessment in pediatric sarcomas has relied on imaging studies and surgical/histopathological evidence of vital tumor cells. Such studies and evidence collection processes often involve radiation and/or
Externí odkaz:
https://doaj.org/article/0198551fa5fa4c2ba508f1cb2000a75d
Autor:
Maria Anna Smolle, Angelika Kogler, Dimosthenis Andreou, Susanne Scheipl, Marko Bergovec, Christoph Castellani, Holger Till, Martin Benesch, Florian Posch, Joanna Szkandera, Freyja-Maria Smolle-Jüttner, Andreas Leithner
Publikováno v:
Cancers, Vol 15, Iss 6, p 1733 (2023)
This retrospective study aimed at analyzing the impact of metastasectomy on post-metastasis survival (PMS) in bone sarcoma patients with lung metastases. Altogether, 47 bone sarcoma patients (24 males, median age at diagnosis of lung metastases: 21.8
Externí odkaz:
https://doaj.org/article/c2c6ef00a02d4448b3fbb1cf3a64b43b
Autor:
Dominik A. Barth, Stefanie Stanzer, Jasmin A. Spiegelberg, Thomas Bauernhofer, Gudrun Absenger, Joanna Szkandera, Armin Gerger, Maria A. Smolle, Georg C. Hutterer, Sascha A. Ahyai, Tobias Madl, Florian Posch, Jakob M. Riedl, Christiane Klec, Philipp J. Jost, Julia Kargl, Martin H. Stradner, Martin Pichler
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundImmune checkpoint inhibitors (ICIs) have revolutionized systemic anti-tumor treatments across different types of cancer. Nevertheless, predictive biomarkers regarding treatment response are not routinely established yet. Apart from T-lympho
Externí odkaz:
https://doaj.org/article/1c7e71b457324a089d3b19334f744c70